Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Health
The Bamboo Works

Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field

Key Takeaways

  • Everest has signed a global licensing deal for an anti-viral Covid treatment being developed by Singapore’s Experimental Drug Development Centre
  • Similar oral anti-viral treatments have been developed by Pfizer and Merck, and are growing in popularity due to their ease of use
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.